The renal vascular response to diabetes

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 1, 2010, Pages 85-90

  Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Afferent arteriole; Diabetes mellitus; Hyperfiltration

Indexed keywords

ARACHIDONIC ACID; C PEPTIDE; CALCIUM ION; CYCLOOXYGENASE 2; GLUCOSE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM CHANNEL; SODIUM; TRANSFORMING GROWTH FACTOR;

ALBUMINURIA; ARTERIAL PRESSURE; ARTERIOLE; AUTOREGULATION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; GLUCOSE TRANSPORT; HUMAN; HYPERTROPHY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; MEMBRANE POTENTIAL; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RENOVASCULAR DISEASE; REVIEW; STREPTOZOCIN DIABETES; ULTRAFILTRATION; VASODILATATION;

ANIMALS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HOMEOSTASIS; HUMANS; ION CHANNELS; KIDNEY; MICROCIRCULATION; MODELS, BIOLOGICAL; RECEPTORS, PURINERGIC P1; RENAL CIRCULATION; VASODILATION;

EID: 73849086629     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32833240fc     Document Type: Review

References (50)

1. Levine DZ. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration? Recognizing clinical and experimental uncertainties. Clin Sci 2008; 114:109-118. This review presents a carefully considered evaluation of the significance of hyperfiltration as a risk factor for development of diabetic nephropathy, a brief summary of which rodent models display hyperfiltration and structural lesions of diabetic nephropathy, and an evaluation of the potential role of nitric oxide in diabetic hyperfiltration.
2. Magee GM, Bilous RW, Cardwell CR, et al.. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009; 52:691-697.
3. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19:410-415.
4. O'Donnell MP, Kasiske BL, Keane WF. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J 1988; 2:2339-2347.
5. Komers R, Lindsley JN, Oyama TT, et al.. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 2001; 107:889-898.
6. Michels LD, Davidman M, Keane WF. Determinants of glomerular filtration and plasma flow in experimental diabetic rats. J Lab Clin Med 1981; 98:869-885.
7. Carmines PK, Bast JP, Ishii N. Altered renal microvascular function in early diabetes. In: Cortes P, Mogensen CE, editors. The diabetic kidney. Totowa, NJ: Humana Press; 2006. pp. 23-36.
8. Bell TD, DiBona GF, Biemiller R, et al.. Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked. Am J Physiol Renal Physiol 2008; 295:F1449-F1456.
9. Veelken R, Hilgers KF, Hartner A, et al.. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000; 11:71-79.
10. Komers R, Allen TJ, Cooper ME. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 1994; 43:1190-1197.
11. Palm F, Buerk DG, Carlsson PO, et al.. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes 2005; 54:3282-3287.
12. Satoh M, Fujimoto S, Arakawa S, et al.. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol Dial Transplant 2008; 23:3806-3813.
13. Ohishi K, Carmines PK. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 1995; 5:1559-1566.
14. Edgley AJ, Tare M, Evans RG, et al.. In vivo regulation of endotheliumdependent vasodilation in the rat renal circulation and the effect of streptozotocin- induced diabetes. Am J Physiol Regul Integr Comp Physiol 2008; 295:R829-R839.
15. Schnackenberg CG, Wilcox CS. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 2001; 59: 1859-1864.
16. Dai F-X, Diederich A, Skopec J, et al.. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol 1993; 4:1327-1336.
17. Rebsomen L, Khammar A, Raccah D, et al.. C-peptide effects on renal physiology and diabetes. Exp Diabetes Res 2008; 2008:281536.
18. Vague P, Coste TC, Jannot MF, et al.. C-peptide, Na+,K+-ATPase, and diabetes. Exp Diabesity Res 2004; 5:37-50.
19. Nordquist L, Lai EY, Sjoquist M, et al.. Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism. Am J Physiol Regul Integr Comp Physiol 2008; 294:R836-R841.
20. Forst T, Kunt T, Wilhelm B, et al.. Role of C-peptide in the regulation of microvascular blood flow. Exp Diabetes Res 2008; 2008:176245.
21. Li J, Chen YJ, Quilley J. Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat. J Pharmacol Exp Ther 2005; 314:818-824.
22. Chen YJ, Li J, Quilley J. Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat. Eur J Pharmacol 2006; 541:80-86.
23. Cherney DZI, Miller JA, Scholey JW, et al.. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes. Diabetes 2008; 57:688-695.
24. Cherney DZI, Scholey JW, Nasrallah R, et al.. Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus. Am J Physiol Renal Physiol 2008; 294:F1336-F1341.
25. Maric C. Sex, diabetes and the kidney. Am J Physiol Renal Physiol 2009; 296:F680-F688.
26. Ikenaga H, Bast JP, Fallet RW, et al.. Exaggerated impact of ATP-sensitive K+ channels on afferent arteriolar diameter in diabetes mellitus. J Am Soc Nephrol 2000; 11:1199-1207.
27. Troncoso Brindeiro CM, Fallet RW, Lane PH, et al.. Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney. Am J Physiol Renal Physiol 2008; 295:F171-F178.
28. Carmines PK, Ohishi K, Ikenaga H. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J Clin Invest 1996; 98:2564-2571.
29. Troncoso Brindeiro CM, Fallet RW, Carmines PK. Effect of tempol on inwardrectifier K channel regulation of afferent arteriolar tone in diabetic rat kidney [abstract]. FASEB J 2009; 23:804.9.
30. Bidani AK, Picken M, Hacioglu R, et al.. Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am J Physiol Renal Physiol 2007; 292:F647-F654.
31. Hayashi K, Epstein M, Loutzenhiser R, et al.. Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J Am Soc Nephrol 1992; 2:1578-1586.
32. Hayashi K, Kanda T, Homma K, et al.. Altered renal microvascular response in Zucker obese rats. Metabolism 2002; 51:1553-1561.
33. Vallon V, Blantz RC, Thomson S. Homeostatic efficiency of tubuloglomerular feedback is reduced in established diabetes mellitus in rats. Am J Physiol Renal Fluid Electrolyte Physiol 1995; 269:F876-F883.
34. Parving H-H, Kastrup H, Smidt UM, et al.. Imparied autoregulation of glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 1981; 20:451-456.
35. Ishida K, Ishibashi F, Takashina S. Comparison of renal hemodynamics in early noninsulin-dependent and insulin-dependent diabetes mellitus. J Diabet Complications 1991; 5:143-145.
36. Bell TD, DiBona GF, Wang Y, et al.. Mechanisms for renal blood flow control early in diabetes as revealed by chronic flow measurement and transfer function analysis. J Am Soc Nephrol 2006; 17:2184-2192.
37. Hashimoto S, Yamada K, Kawata T, et al.. Abnormal autoregulation and tubuloglomerular feedback in prediabetic and diabetic OLETF rats. Am J Physiol Renal Physiol 2009; 296:F598-F604.
38. Hashimoto Y, Ideura T, Yoshimura A, et al.. Autoregulation of renal blood flow in streptozocin-induced diabetic rats. Diabetes 1989; 38:1109-1113.
39. Lau C, Sudbury I, Thomson M, et al.. Salt-resistant blood pressure and saltsensitive renal autoregulation in chronic streptozotocin diabetes. Am J Physiol Regul Integr Comp Physiol 2009; 296:R1761-R1770.
40. De Micheli AG, Forster H, Duncan RC, et al.. A quantitative assessment of renal blood flow autoregulation in experimental diabetes. Nephron 1994; 68:245-251.
41. Mauer SM, Brown DM, Steffes MW, et al.. Studies of renal autoregulation in pancreatectomized and streptozotocin diabetic rats. Kidney Int 1990; 37:909-917.
42. Park S, Bivona BJ, Feng Y, et al.. Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice. Am J Physiol Renal Physiol 2008; 295:F1504-F1511.
43. Griffin KA, Abu-Naser M, Abu-Amarah I, et al.. Dynamic blood pressure load and nephropathy in the ZSF1 ( fa/facp) model of type 2 diabetes. Am J Physiol Renal Physiol 2007; 293:F1605-F1613.
44. Schjoedt KJ, Christensen PK, Jorsal A, et al.. Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial. Nephrol Dial Transplant 2009 [Epub ahead of print]
45. Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol 2003; 14:530-537.
46. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004; 286:F8-F15.
47. Levine DZ, Iacovitti M, Robertson SJ, et al.. Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2006; 290:R975-R981.
48. Sä llströmJ, Carlsson PO, Fredholm BB, et al.. Diabetes-induced hyperfiltration in adenosine A1-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiologica 2007; 190:253-259.
49. Faulhaber-Walter R, Chen L, Oppermann M, et al.. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol 2008; 19:722-730.
50. Vallon V, Schroth J, Satriano J, et al.. Adenosine A1 receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus. Nephron Physiol 2009; 111:30-38.